Interesting, would you say Leronlimab is the super
Post# of 148175
The float is low and the market cap is low as well. I see it as a good investment short term, but I however want cydy to shine for all the other indications. We have so much more to offer.
HGEN only has covid going for them maybe ADRS?
I’m sure everyone is like me waiting for the results. Tough waiting.